Duration of Antifungal Therapy When Blood Cultures Cannot Be Performed

Rationale for This Approach

The Infectious Diseases Society of America recommends treating for a minimum of 14 days from the time clinical signs and symptoms of candidemia have completely resolved, using clinical improvement as the primary endpoint, with a strength of evidence based on prospective randomized trials 1, 2
The standard recommendation is 14 days after documented clearance of Candida from the bloodstream plus resolution of symptoms, but when blood cultures are unavailable, treatment duration must rely entirely on clinical parameters 1, 2, 3

Base treatment duration on complete resolution of fever and hemodynamic instability, leukocytosis or other laboratory markers of infection, source control achievement, and any organ-specific symptoms attributable to candidemia 1, 2
The American College of Physicians recommends monitoring for resolution of symptoms such as fever, as well as laboratory markers and source control, to determine treatment duration 1, 2

The minimum treatment duration should be 14 days from when the patient becomes clinically stable and asymptomatic, based on prospective randomized trials with few complications and relapses 1, 2, 3

For neutropenic patients, the Infectious Diseases Society of America recommends treating for 14 days after clinical resolution and resolution of neutropenia, with an absolute neutrophil count >500 cells/μL 4, 5, 6
For neonates, the Pediatric Infectious Diseases Society recommends a minimum of 3 weeks of treatment from clinical improvement, due to the higher risk of disseminated disease 4

Perform a dilated funduscopic examination within the first week to exclude endophthalmitis, as 16% of candidemia patients have ocular involvement, and undetected endophthalmitis requires extended therapy duration 1, 2, 4
Remove all central venous catheters as early as safely possible, as catheter retention significantly worsens outcomes 1, 2, 3
Consider imaging to exclude metastatic complications if fever persists beyond 72 hours of appropriate therapy or if there are localizing symptoms 4, 8

Do not stop therapy prematurely, just because the patient appears clinically improved at 7-10 days—complete the full 14-day course after symptom resolution, as delays in initiating appropriate therapy increase mortality 1, 2, 3
Do not assume absence of symptoms equals clearance—without blood cultures, be more conservative and ensure at least 14 days of treatment from complete clinical resolution 1, 2
Do not skip the ophthalmologic examination, as this is the only way to detect endophthalmitis that would require extended therapy duration 1, 2